9
Participants
Start Date
August 28, 2018
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
BBB Disruption with Chemotherapy Arm
The ExAblate BBB disruption of targets associated with enhancing post-resection MRI imaging procedure will be performed with ExAblate 4000 type 2.0 system and will coincide with on one of three first days of each planned TMZ adjuvant therapy cycle as one procedure per cycle.
Severance Hospital, Yonsei University Health System, Seoul
Lead Sponsor
InSightec
INDUSTRY